MURPHY JOHN RAYMOND 4
4 · Cadrenal Therapeutics, Inc. · Filed Mar 22, 2023
Insider Transaction Report
Form 4
MURPHY JOHN RAYMOND
Director
Transactions
- Purchase
Common Stock
2023-03-21$1.39/sh+10,000$13,900→ 594,792 total
Footnotes (1)
- [F1]The amount of securities beneficially owned by Mr. Murphy following the reported transaction is correctly reported on this Form 4. The amount of securities beneficially owned by Mr. Murphy has been adjusted to correct immaterial errors in prior Form 4 filings that were filed with the Securities and Exchange Commission on January 24, 2023 and March 16, 2023.